305 related articles for article (PubMed ID: 28187757)
1. The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit.
Bhargava V; Malloy M; Fonseca R
BMC Pediatr; 2017 Feb; 17(1):50. PubMed ID: 28187757
[TBL] [Abstract][Full Text] [Related]
2. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
Reilly AM; Ding MX; Rower JE; Kiser TH
J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089
[TBL] [Abstract][Full Text] [Related]
3. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
[TBL] [Abstract][Full Text] [Related]
4. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.
Ramírez E; Jiménez C; Borobia AM; Tong HY; Medrano N; Krauel-Bidwell L; Carcas AJ; Selgas R; Frías J
Ther Drug Monit; 2013 Jun; 35(3):360-6. PubMed ID: 23666575
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit.
Qian X; Du G; Weng C; Zhou H; Zhou X
Int J Infect Dis; 2017 Jul; 60():17-22. PubMed ID: 28457752
[TBL] [Abstract][Full Text] [Related]
7. Dose regimen for vancomycin not needing serum peak levels?
Tan WH; Brown N; Kelsall AW; McClure RJ
Arch Dis Child Fetal Neonatal Ed; 2002 Nov; 87(3):F214-6. PubMed ID: 12390995
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients.
Moffett BS; Hilvers PS; Dinh K; Arikan AA; Checchia P; Bronicki R
Congenit Heart Dis; 2015; 10(1):E6-10. PubMed ID: 24934335
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
10. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.
Pritchard L; Baker C; Leggett J; Sehdev P; Brown A; Bayley KB
Am J Med; 2010 Dec; 123(12):1143-9. PubMed ID: 21183005
[TBL] [Abstract][Full Text] [Related]
11. Assessment of initial vancomycin trough levels and risk factors of vancomycin-induced nephrotoxicity in neonates.
Dawoud TH; Khan N; Afzal U; Varghese N; Rahmani A; Abu-Sa'da O
Eur J Hosp Pharm; 2022 Jan; 29(1):44-49. PubMed ID: 34930794
[TBL] [Abstract][Full Text] [Related]
12. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
Horey A; Mergenhagen KA; Mattappallil A
Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
[TBL] [Abstract][Full Text] [Related]
13. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
[TBL] [Abstract][Full Text] [Related]
14. Risk of Acute Kidney Injury Based on Vancomycin Target Trough Attainment Strategy: Area-Under-the-Curve-Guided Bayesian Software, Nomogram, or Trough-Guided Dosing.
Knight JM; Iso T; Perez KK; Swan JT; Janak CE; Ikwuagwu JO; Musick WL
Ann Pharmacother; 2024 Feb; 58(2):110-117. PubMed ID: 37144736
[TBL] [Abstract][Full Text] [Related]
15. A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates.
Constance JE; Balch AH; Stockmann C; Linakis MW; Korgenski EK; Roberts JK; Ward RM; Sherwin CM; Spigarelli MG
Arch Dis Child Fetal Neonatal Ed; 2016 May; 101(3):F236-43. PubMed ID: 26400103
[TBL] [Abstract][Full Text] [Related]
16. Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy.
Knoderer CA; Gritzman AL; Nichols KR; Wilson AC
Ann Pharmacother; 2015 Oct; 49(10):1113-9. PubMed ID: 26160972
[TBL] [Abstract][Full Text] [Related]
17. Individualized Pharmacokinetic Dosing of Vancomycin Reduces Time to Therapeutic Trough Concentrations in Critically Ill Patients.
Truong J; Smith SR; Veillette JJ; Forland SC
J Clin Pharmacol; 2018 Sep; 58(9):1123-1130. PubMed ID: 29957824
[TBL] [Abstract][Full Text] [Related]
18. Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients.
Buhlinger KM; Fuller KA; Faircloth CB; Wallace JR
Am J Health Syst Pharm; 2019 Aug; 76(16):1204-1210. PubMed ID: 31369115
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.
Irikura M; Fujiyama A; Saita F; Fukushima S; Kitaoka H; Fukuda T; Kawase A; Kondo Y; Ishitsuka Y; Kondo G; Maeda T; Yukawa E; Irie T
Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis.
Abdelmessih E; Patel N; Vekaria J; Crovetto B; SanFilippo S; Adams C; Brunetti L
Pharmacotherapy; 2022 Sep; 42(9):741-753. PubMed ID: 35869689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]